10:09 AM EST, 02/13/2026 (MT Newswires) -- (Updates with recent stock movement in the headline and the first paragraph.)

Moderna ( MRNA ) shares were up nearly 8% in recent Friday trading after the company reported a narrower-than-expected Q4 net loss and revenue that topped analyst estimates.

The company reported a Q4 net loss Friday of $2.11 per diluted share, narrowing from $2.91 a year earlier.

Analysts polled by FactSet expected a net loss of $2.51 per share.

Revenue for the quarter ended Dec. 31 was $678 million, compared with $966 million a year earlier.

Analysts polled by FactSet expected $635.2 million.

The company said it continues to target a 10% revenue growth in 2026. Analysts polled by FactSet expect $2.02 billion.

Price: 43.21, Change: +3.10, Percent Change: +7.73